QLS-21908

N/A

Report date: 2022/04/26 17:54:49

Base Information

Drug NameQLS-21908
Drug Alias NameQLS-21908
ClassificationBiologics
Mechanisms of ActionLow affinity immunoglobulin gamma Fc region receptor II-a antagonists
TargetsLow affinity immunoglobulin gamma Fc region receptor II-a
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesQilu Pharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesQilu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A